We are live on !
Find out more
Aspect Partners Portfolio holdings
AUM
$264M
Turnover
5.16%
1-Year Est. Return
15.76%
This Fund
S&P 500
This Quarter Est. Return
+1.02%
1 Year Est. Return
+15.76%
3 Year Est. Return
+66.73%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$264M
AUM Growth
-$3.69M
(-1.4%)
Cap. Flow
-$4.8M
Cap. Flow % of AUM
Cap. Flow %
-1.81%
Top 10 Holdings %
Top 10 Hldgs %
59.87%
Holding
698
New
19
Increased
176
Reduced
151
Closed
17
Avg Time Held
2
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$20.1M |
| 2 |
Distillate Small/Mid Cash Flow ETF
DSMC
|
+$846K |
| 3 |
abrdn Physical Gold Shares ETF
SGOL
|
+$670K |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$566K |
| 5 |
Cambria Foreign Shareholder Yield ETF
FYLD
|
+$529K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.9M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$8.8M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$7.76M |
| 4 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$1.52M |
| 5 |
Alpha Architect 1-3 Month Box ETF
BOXX
|
+$873K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.19% |
| 2 | Technology | 1.89% |
| 3 | Financials | 0.81% |
| 4 | Consumer Discretionary | 0.53% |
| 5 | Industrials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
Albemarle
ALB
$11.1B
| $3.81K | ﹤0.01% |
36
-13
| -27% | -$1.61K |
2025 Q4
3 quarters
|
|
452
Regeneron Pharmaceuticals
REGN
$82.9B
| $3.79K | ﹤0.01% |
5
| – | – |
2023 Q4
11 quarters
|
|
453
X-Energy Inc
XE
$3.05B
| $3.79K | ﹤0.01% |
267
+28
| +12% | +$482 |
2026 Q2
1 quarter
|
|
454
Dyne Therapeutics
DYN
$2.92B
| $3.75K | ﹤0.01% |
233
| – | – |
2023 Q4
11 quarters
|
|
455
BioMarin Pharmaceuticals
BMRN
$10.8B
| $3.66K | ﹤0.01% |
61
+2
| +3% | +$126 |
2026 Q1
2 quarters
|
|
456
Archer Aviation
ACHR
$3.01B
| $3.64K | ﹤0.01% |
732
+18
| +3% | +$98 |
2025 Q1
6 quarters
|
|
457
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.1B
| $3.57K | ﹤0.01% |
23
| – | – |
2023 Q4
11 quarters
|
|
458
Hilton Worldwide
HLT
$78.7B
| $3.5K | ﹤0.01% |
11
-1
| -8% | -$321 |
2023 Q4
11 quarters
|
|
459
Regency Centers
REG
$13.5B
| $3.45K | ﹤0.01% |
48
+2
| +4% | +$155 |
2023 Q4
11 quarters
|
|
460
Reaves Utility Income Fund
UTG
$3.11B
| $3.44K | ﹤0.01% |
100
| – | – |
2024 Q2
9 quarters
|
|
461
C.H. Robinson
CHRW
$16.3B
| $3.4K | ﹤0.01% |
23
-20
| -47% | -$3.26K |
2026 Q2
1 quarter
|
|
462
USA Rare Earth Inc
USAR
$3.5B
| $3.38K | ﹤0.01% |
240
+3
| +1% | +$51 |
2025 Q3
4 quarters
|
|
463
American Water Works
AWK
$28.4B
| $3.37K | ﹤0.01% |
26
| – | – |
2023 Q4
11 quarters
|
|
464
Legend Biotech
LEGN
$3.75B
| $3.36K | ﹤0.01% |
169
+9
| +6% | +$192 |
2025 Q4
3 quarters
|
|
465
Textron
TXT
$13.2B
| $3.35K | ﹤0.01% |
44
-7
| -14% | -$597 |
2023 Q4
11 quarters
|
|
466
Doximity
DOCS
$5.95B
| $3.34K | ﹤0.01% |
118
+4
| +4% | +$97 |
2025 Q2
5 quarters
|
|
467
Krystal Biotech
KRYS
$9.22B
| $3.33K | ﹤0.01% |
10
| – | – |
2026 Q2
1 quarter
|
|
468
EOG Resources
EOG
$85.5B
| $3.31K | ﹤0.01% |
24
-1
| -4% | -$143 |
2023 Q4
11 quarters
|
|
469
Quest Diagnostics
DGX
$26.7B
| $3.26K | ﹤0.01% |
14
| – | – |
2023 Q4
11 quarters
|
|
470
AGNC Investment
AGNC
$10.5B
| $3.25K | ﹤0.01% |
359
+12
| +3% | +$127 |
2023 Q4
11 quarters
|
|
471
TransDigm Group
TDG
$61.1B
| $3.25K | ﹤0.01% |
3
| – | – |
2023 Q4
11 quarters
|
|
472
Pentair
PNR
$8.83B
| $3.23K | ﹤0.01% |
61
-44
| -42% | -$2.8K |
2023 Q4
11 quarters
|
|
473
Veralto
VLTO
$25.4B
| $3.11K | ﹤0.01% |
33
+17
| +106% | +$1.62K |
2023 Q4
11 quarters
|
|
474
Generac Holdings
GNRC
$11B
| $3.1K | ﹤0.01% |
15
| – | – |
2026 Q2
1 quarter
|
|
475
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.2B
| $3.1K | ﹤0.01% |
74
| – | – |
2026 Q2
1 quarter
|
|
Similar funds
Aspect Partners's Q3 2026 Portfolio in Review
As of Q3 2026, Aspect Partners held 698 positions worth $264M, down 1.4% from $268M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Aspect Partners's Q3 2026 filing shows 19 new, 176 increased, 151 reduced and 17 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 245,690 shares worth $20M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $9.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 95% a quarter earlier, followed by Technology and Financials.
- Aspect Partners's largest Q3 2026 buy was iShares 1-3 Year Treasury Bond ETF: 245,690 shares worth $20M.
- Aspect Partners added most to Distillate Small/Mid Cash Flow ETF in Q3 2026, an estimated $846K increase.
- Aspect Partners's biggest Q3 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $9.9M.
- Aspect Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q3 2026, selling an estimated $27.5K.
- Aspect Partners's ten largest holdings make up 60% of its $264M portfolio in Q3 2026.
- Aspect Partners opened 19 new positions and closed 17 in Q3 2026.
- Aspect Partners's portfolio value fell 1.4% quarter-over-quarter to $264M.
Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.